Lunch Activity/Non-CE Accredited Satellite Symposium: Thrombotic Risk and Symptom Assessment in Patients With Polycythemia Vera | A Collaborative Approach to Identifying When to Intervene With Jakafi® (ruxolitinib) Incyte Corporation
Friday, November 15, 2024
12:35 PM – 2:00 PM CT
Location: Dallas 5
Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO Duke University School of Medicine
Maria Wood, BA, BHS, MPAS, PA-C, DMSc Tennessee Oncology
